JP2003052361A - Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture - Google Patents

Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture

Info

Publication number
JP2003052361A
JP2003052361A JP2001243948A JP2001243948A JP2003052361A JP 2003052361 A JP2003052361 A JP 2003052361A JP 2001243948 A JP2001243948 A JP 2001243948A JP 2001243948 A JP2001243948 A JP 2001243948A JP 2003052361 A JP2003052361 A JP 2003052361A
Authority
JP
Japan
Prior art keywords
cells
cell
substrate
aggregate
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001243948A
Other languages
Japanese (ja)
Inventor
Naohiko Yoshida
尚彦 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shinano Kenshi Co Ltd
Original Assignee
Shinano Kenshi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinano Kenshi Co Ltd filed Critical Shinano Kenshi Co Ltd
Priority to JP2001243948A priority Critical patent/JP2003052361A/en
Publication of JP2003052361A publication Critical patent/JP2003052361A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a base plate for forming an aggregate with a controlled outline for adhesion-depending cells, with which base plate culture cells can grow for a long time by mutually giving a foothold by adhering between cells even when the cells flow on a culture liquid. SOLUTION: The base plate 11 is formed of a non-cell adhesive material to which culturing cells do not adhere, and it has dent parts 13 for controlling the outlines of cell aggregates formed by adhering between cells seeded.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は接着依存性細胞の外
形制御集合体形成用基板および細胞培養方法に関する。
TECHNICAL FIELD The present invention relates to a substrate for forming an outline control aggregate of adhesion-dependent cells and a cell culture method.

【0002】[0002]

【従来技術】新薬開発の際、一つの市販製品(新薬)を
開発するために、数百億円とも言われる費用が投入され
る。その費用の多くは、動物実験を中心とした薬物候補
物質の毒性評価試験に用いられている。そもそも、新薬
開発とは、薬効が認められたある一つの化学物質に化学
的修飾を施し、薬効が最大で、かつ副作用が最低となる
分子構造を発見する作業である。この際、開発初期にお
いては、多種多様に化学修飾を施した新薬候補物質一つ
一つに対し、それぞれ動物実験による毒性試験等を行っ
て、毒性の強い薬品のスクリーニングを行うが、新薬候
補物質の数が非常に多いため、極めて多数の実験動物を
死なせてしまうことになる。これら動物が非常に高価で
あることから、創薬早期における毒性評価のための動物
実験にかかる費用は莫大なものとなる。また、動物愛護
上の観点から、動物実験に対する国際的な批判が増して
きており、動物実験を代替しうる、もしくは大幅に減少
させうる創薬ツールの開発が急がれている。近年、この
創薬ツールとして注目を集め、一部実用化されているの
は、生体外で細胞を培養、生育させた培養細胞である。
これを用いて新規薬剤の生理活性や毒性を試験すること
が行われている。しかしながら、実用化されているのは
主に培養・増殖が容易な皮膚細胞であり、創薬ツールと
して真に望まれている、生体内で薬物代謝を担う細胞
(例:肝細胞、腎細胞)を用いた培養細胞は、体外では
その機能を十分発揮する培養系が存在しないため、いま
だ実用化には至っていない。上記のような培養細胞を得
るには、現在のところ、次のような方法が主に用いられ
ている。最も一般的な方法は、培養皿にコラーゲン等の
細胞接着性のタンパク質を担体として均一にコートし、
培養液を供給し、細胞を播種して、細胞を担体に接着せ
しめ、生育を行う方法である。あるいは、細胞の接着の
容易さが異なるような表面パターンに形成した基板を用
い、この基板表面で細胞培養を行い、接着の容易な部位
にのみ細胞を接着させることにより、基板上に細胞を配
列させる技術も開発されてきている。さらに、特定の細
胞では細胞非接着性基板上に細胞を播種した場合にお互
いに接着し合い、球状のスフェロイドと呼ばれる細胞集
合体を形成する場合がある。この場合は、細胞は基盤に
接着せずともお互いに足場を供給しあうことによって生
存を長期に保持することが知られている。
2. Description of the Related Art When developing a new drug, a cost of several tens of billions of yen is invested to develop one commercial product (new drug). Most of the cost is used for toxicity evaluation tests of drug candidates, mainly in animal experiments. In the first place, the development of a new drug is the work of chemically modifying one chemical substance that has been found to have a drug effect, and discovering the molecular structure with the maximum drug effect and the minimum side effect. At this time, in the early stages of development, each new drug candidate substance that has been subjected to a wide variety of chemical modifications is subjected to toxicity tests, etc. by animal experiments to screen for highly toxic drugs. Due to the large number of animals, an extremely large number of experimental animals will be killed. Since these animals are very expensive, the cost of animal experiments for toxicity evaluation in the early stages of drug discovery becomes enormous. In addition, from the viewpoint of animal welfare, international criticism of animal experiments is increasing, and there is an urgent need to develop drug discovery tools that can replace or greatly reduce animal experiments. In recent years, what has attracted attention as a drug discovery tool and has been partially put into practical use is a cultured cell obtained by culturing and growing the cell in vitro.
This is used to test the physiological activity and toxicity of new drugs. However, the skin cells that are practically used are mainly skin cells that are easy to culture and proliferate, and cells that are responsible for drug metabolism in the body that are truly desired as drug discovery tools (eg, hepatocytes, kidney cells). The cultured cells using Escherichia coli have not yet been put to practical use because there is no culture system that exerts their functions sufficiently outside the body. At present, the following methods are mainly used to obtain the above-mentioned cultured cells. The most common method is to uniformly coat a culture dish with a cell-adhesive protein such as collagen as a carrier,
This is a method in which a culture solution is supplied, cells are seeded, the cells are allowed to adhere to a carrier, and growth is performed. Alternatively, by arranging cells on the substrate by using a substrate formed with a surface pattern in which cell adhesion is different, culturing cells on the surface of the substrate, and adhering the cells only to sites where they can easily adhere. Techniques for making it happen have also been developed. Furthermore, in the case of specific cells, when the cells are seeded on a cell non-adhesive substrate, they may adhere to each other to form a cell aggregate called a spherical spheroid. In this case, it is known that the cells maintain their survival for a long time by supplying scaffolds to each other without adhering to the base.

【0003】[0003]

【発明が解決しようとする課題】生体内で薬物代謝にか
かわる細胞が、生体外で培養された場合にその本来の機
能を発揮できない主な理由は、細胞同士の三次元的配列
が体外で再現できないためであると考えられている。体
外での細胞培養では、主に細胞を平面上に播種する方法
が用いられるが、この状態は生体内における細胞の状態
とはかけ離れていると言わざるを得ない。さらに、上記
の一般的細胞培養方法を用いて細胞を培養し、培養基板
に細胞が接着してしまうと、細胞にダメージを与えずに
別の部位に移植することが非常に困難であるという課題
もある。スフェロイドを形成する場合には、基板に接着
していないので別の部位への移植は比較的容易だが、形
状・大きさの制御が困難であり、特に大きさが大きくな
りすぎてしまうと、スフェロイドの中心部に存在する細
胞では老廃物の排泄、栄養や酸素の取り込みがうまく機
能せず、中心部から集合体が死亡してしまうことが明ら
かになっている。そこで、上記の問題点を解決するため
には、細胞同士の位置や、細胞が集合した場合の形状を
制御しうる培養系を確立することが大きな課題である。
The main reason why cells involved in drug metabolism in vivo cannot exert their original functions when cultured in vitro is that the three-dimensional arrangement of cells is reproduced in vitro. It is believed that this is because it is not possible. In in vitro cell culture, a method of seeding cells on a flat surface is mainly used, but it must be said that this state is far from the state of cells in a living body. Furthermore, when cells are cultured using the above-mentioned general cell culture method and the cells adhere to the culture substrate, it is very difficult to transplant them to another site without damaging the cells. There is also. When forming spheroids, it is relatively easy to transplant to another site because it is not adhered to the substrate, but it is difficult to control the shape and size, and if the size becomes too large, the spheroids will grow. It has been revealed that the cells existing in the central part of the plant do not function well in excretion of waste products, uptake of nutrients and oxygen, and the aggregate dies from the central part. Therefore, in order to solve the above problems, it is a major problem to establish a culture system capable of controlling the positions of cells and the shape of cells when they are aggregated.

【0004】本発明者は、上記課題に鑑み、鋭意研究を
重ねた結果、驚くべきことに、凹部を持ったアガロース
ゲル基板を培養用基板として用いることで、細胞を浮遊
させたまま細胞集合体を形成させ、かつその形状を制御
しうることを見出し、本発明を完成させた。
As a result of earnest studies in view of the above-mentioned problems, the present inventor has surprisingly used an agarose gel substrate having a concave portion as a culture substrate so that cell aggregates can be obtained while cells are suspended. The present invention has been completed based on the finding that it is possible to form a film and control its shape.

【0005】[0005]

【課題を解決するための手段】本発明に係る接着依存性
細胞の外形制御集合体形成用基板は、培養される細胞が
接着しない、非細胞接着性の材料からなり、播種された
細胞同士が接着して形成される細胞集合体の外形を規制
する凹部を有することを特徴としている。非接着性の材
料にアガロースゲルを用いることができる。アガロース
は、多糖類であり、水酸基を多く有していて親水性をも
つ。アガロースゲルには、ほとんど細胞が接着しないこ
とはよく知られている。このアガロースゲルはゲル化し
た後は保形性を有するので、成形型を用いて必要な形状
に容易に成形することができる。なお、細胞非接着性材
料はアガロースゲルに限定されることはなく、成形性が
あり、なおかつ細胞接着性のない素材であればいかなる
素材でもよい。
A substrate for forming an outer shape control aggregate of adhesion-dependent cells according to the present invention is made of a non-cell-adhesive material to which cultured cells do not adhere, and seeded cells are It is characterized by having a concave portion that regulates the outer shape of the cell aggregate formed by adhesion. Agarose gel can be used as the non-adhesive material. Agarose is a polysaccharide that has many hydroxyl groups and is hydrophilic. It is well known that almost no cells adhere to agarose gel. Since this agarose gel has a shape-retaining property after gelling, it can be easily molded into a required shape using a molding die. The cell non-adhesive material is not limited to agarose gel, and may be any material as long as it has moldability and does not have cell adhesiveness.

【0006】また本発明に係る細胞培養方法は、上記の
接着依存性細胞の外形制御集合体形成用基板を培養容器
に収容し、該基板上に培養液を供給し、前記基板凹部内
に多数の細胞を播種し、所要条件に維持して、基盤凹部
底部に沈殿した細胞同士を互いに接着させて、多数の細
胞が接着した細胞集合体の外形がほぼ凹部の形状に沿う
ように凹部壁面で規制しつつ、生育させることを特徴と
するものである。
Further, in the cell culture method according to the present invention, the above-mentioned substrate for forming the outer shape control aggregate of adhesion-dependent cells is housed in a culture container, a culture solution is supplied onto the substrate, and a large number of the substrate are placed in the recesses of the substrate. Cells are seeded and maintained under the required conditions, the cells precipitated at the bottom of the base recess are adhered to each other, and the outer shape of the cell aggregate to which a large number of cells have adhered is substantially aligned with the shape of the recess on the recess wall surface. It is characterized in that it is allowed to grow while being regulated.

【0007】播種された細胞は、培養初期は粒状で互い
に独立しているが、やがて隣接する細胞同士互いに接触
して、細胞集合体を形成する。接触部位は互いに接着
し、接着した部位が足場となって、接着依存性を有する
細胞であっても長期間生存が可能であることが確認され
た。さらに、驚くべきことに集合体の外形(輪郭)は凹
部の形状に規制され、従来の球状とは異なった形の細胞
集合体が得られることが明らかになった。凹部の形状は
その整形型の形状に応じて任意であり、したがって整形
型が加工可能な形状である限り、任意の形状の細胞集合
体とすることができる。例えば肝実質細胞の培養をする
とき、生体内の肝実質細胞が棒状に平行に並んだ形態を
とっていることを模倣し、凹部を平行な溝形状に形成す
ることにより、生体内とよく似た線状肝実質細胞集合体
とすることができる。培養液や、培養、生育条件は特に
特別なものを必要とせず、通常の培養液、条件で行うこ
とができる。
The seeded cells are granular and independent of each other in the initial stage of culture, but eventually adjacent cells come into contact with each other to form cell aggregates. It was confirmed that the contact sites adhere to each other, and the adhered sites serve as a scaffold, and even cells having an adhesion dependency can survive for a long period of time. Furthermore, it was revealed that, surprisingly, the outer shape (contour) of the aggregate was restricted to the shape of the recess, and a cell aggregate having a shape different from the conventional spherical shape was obtained. The shape of the concave portion is arbitrary depending on the shape of the shaping mold, and thus, the cell aggregate having any shape can be used as long as the shaping mold is a processable shape. For example, when culturing hepatic parenchymal cells, it mimics the fact that hepatic parenchymal cells in a living body are arranged in parallel in a rod shape, and by forming recesses in parallel groove shapes, it is very similar to that in the living body. It can be a linear hepatocyte aggregate. The culture medium and the culture and growth conditions do not need to be particularly special, and the culture medium and the usual conditions can be used.

【0008】肝細胞以外にも、細胞同士が接着するタイ
プの細胞、例えば、筋肉細胞、神経細胞、血管内皮細
胞、内分泌系細胞、皮膚/粘膜細胞など、接着性を持つ
細胞の集合体を任意の形状で得ることができる。この細
胞集合体は、培養液上に浮遊しており、基板に接着して
いないから、ピペット(スポイトの一種)等で容易に吸
引、回収でき、細胞を破壊せずに他の部位に移植ができ
る。すなわち、任意の形状に整形を行った状態で種々の
用途に転用できることになる。
In addition to hepatocytes, any type of cells that adhere to each other, such as muscle cells, nerve cells, vascular endothelial cells, endocrine cells, skin / mucosal cells, etc., can be used. Can be obtained in the shape of. Since the cell aggregates are suspended in the culture medium and not attached to the substrate, they can be easily aspirated and collected with a pipette (a kind of dropper), etc., and can be transplanted to other sites without destroying the cells. it can. That is, it can be diverted to various uses while being shaped into an arbitrary shape.

【0009】例えば、生体内での細胞間の位置関係、集
合体形状を、上記のようにして体外の培養系で培養した
種々の培養細胞を移植して復元することにより、その細
胞間の直接接触による情報伝達や、形状に起因する機能
(筋肉の収縮機能など)の再生が行える。また、集合体
化した肝細胞を極性誘導が可能な材料を利用した基板上
に再播種することで、細胞が生体内でもっていた極性構
造の復活が期待できる。また、肝臓内での肝実質細胞
は、周りを種々の非実質細胞で囲まれた線状の形状をも
った集合体であり、上記のように作成が可能になった線
状肝細胞集合体を用いることで、人工肝臓への応用が期
待できる。
For example, the positional relationship between cells in a living body and the shape of an aggregate can be directly restored by transplanting various cultured cells cultured in an in vitro culture system as described above to restore them. Information can be transmitted by contact, and functions caused by shape (such as muscle contraction function) can be reproduced. Further, by reseeding the aggregated hepatocytes on a substrate using a material capable of inducing polarity, it can be expected that the polar structure that the cells had in vivo will be restored. Hepatocytes in the liver are linear aggregates surrounded by various non-parenchymal cells, and the linear hepatocyte aggregates that can be created as described above. By using, it can be expected to be applied to an artificial liver.

【0010】[0010]

【実施例】図1はアガロースゲルを用いて作成した基板
11を示す。図のように、複数本の平行な溝(凹部、
谷)13が形成されている。基板11はアガロースゲル
単独で形成してもよいが、ガラス等の支持基体(図示せ
ず)上に支持させてもよい。基板11における溝13の
幅、深さ、山の幅は全て0.1mmとし、溝部が形成さ
れている部分の一辺は1cmの正方形とした。アガロー
スゲルは、アガロースの粉体6wt%を水に混合し、一
旦煮沸させて溶解し、冷却することでゲル状化させ、こ
れを成形型(図示せず)を用いて図に示す形状に成形し
て基板11を形成した。上記基板11を培養皿(培養容
器、図示せず)に収容し、培養皿中に、溝13内にまで
浸るように培養液を供給した。培養液は、PSN(Peni
cillin、Streptomycin、Neomycin:いずれも抗生物質)
が含有されたウイリアムズ メディウム E(Williams
, medium E)90vol%に10vol%のFBS(Fetal b
ovine serum:牛胎児血清)を添加した、一般的な培養液
を用いた。基板11上に、成熟マウス肝実質細胞を8万
個/cm2となるように播種した。この培養皿をインキ
ュベーター(図示せず)中に収容し、温度約37℃、炭
酸ガス濃度約5%の大気雰囲気中で、24時間、培養、
生育させた後の細胞の生育拡大写真を図2に示す。基板
11上に播種された細胞は重力により溝13内に落ち込
む。培養初期の段階では、肝細胞は個々に粒子状であっ
たものが、培養が進行するにつれ、培養液上に個々の細
胞が互いに接触して集合体を形成し始めた。そして、2
4時間経過後は、図2に示されるように、基板11の溝
13内にほぼ一杯になるように集合体が成長した。この
細胞集合体は基板11には接着しておらず、ピペットで
吸引して、容易に他の部位に移植できた。細胞集合体
は、個々の細胞が接着していて、2日間は生存している
ことが確認された。
EXAMPLE FIG. 1 shows a substrate 11 made of agarose gel. As shown in the figure, multiple parallel grooves (recesses,
Valley 13 is formed. The substrate 11 may be formed of agarose gel alone, but may be supported on a supporting substrate (not shown) such as glass. The width, the depth, and the width of the crests of the groove 11 on the substrate 11 were all 0.1 mm, and the side where the groove was formed was a square of 1 cm. The agarose gel is made by mixing 6 wt% of agarose powder with water, boiling it once to dissolve it, and then cooling it into a gel, which is then molded into the shape shown in the figure using a molding die (not shown). Then, the substrate 11 was formed. The substrate 11 was housed in a culture dish (culture vessel, not shown), and a culture solution was supplied into the culture dish so as to be immersed in the groove 13. The culture medium is PSN (Peni
cillin, Streptomycin, Neomycin: All are antibiotics)
Williams Medium E (Williams
, medium E) 90 vol% to 10 vol% FBS (Fetal b)
(Ovine serum: fetal bovine serum) was used as a general culture medium. On the substrate 11, mature mouse hepatocytes were seeded at 80,000 cells / cm 2 . The culture dish was housed in an incubator (not shown), and cultured for 24 hours in an air atmosphere at a temperature of about 37 ° C. and a carbon dioxide concentration of about 5%.
An enlarged photograph of the growth of the cells after growing is shown in FIG. The cells seeded on the substrate 11 fall into the groove 13 by gravity. In the initial stage of culture, hepatocytes were in the form of particles, but as the culture proceeded, the individual cells began to come into contact with each other on the culture medium to form aggregates. And 2
After the lapse of 4 hours, as shown in FIG. 2, the aggregate grew so as to fill the groove 13 of the substrate 11 almost completely. This cell aggregate was not adhered to the substrate 11 and could be easily transplanted to another site by aspirating with a pipette. It was confirmed that the individual cells of the cell aggregate were adhered and survived for 2 days.

【0011】[0011]

【発明の効果】以上のように、本発明に係る接着依存性
細胞の外形制御集合体形成用基板および細胞培養方法に
よれば、生育した細胞がほぼ凹部の形状にならった外形
の細胞集合体を形成した。しかも、この細胞集合体は基
板に接着していないので、細胞にダメージを与えること
なく、容易に他の部位への移植が可能であり、毒性評価
以外にも、立体的に形状を制御された細胞集合体を必要
とする種々の用途に適用可能であるという効果を有す
る。
As described above, according to the substrate for controlling the outer shape control aggregate of adhesion-dependent cells and the method for culturing cells according to the present invention, the cell aggregate having the outer shape in which the grown cells have a substantially concave shape. Was formed. Moreover, since this cell aggregate is not adhered to the substrate, it can be easily transplanted to other sites without damaging the cells, and the shape was three-dimensionally controlled in addition to toxicity evaluation. It has an effect that it can be applied to various uses requiring a cell aggregate.

【図面の簡単な説明】[Brief description of drawings]

【図1】基板の説明図である。FIG. 1 is an explanatory diagram of a substrate.

【図2】24時間培養、生育後の細胞集合体を示す写真
図である。
FIG. 2 is a photograph showing cell aggregates after 24 hours of culture and growth.

【符号の説明】[Explanation of symbols]

11 基板 13 溝(凹部) 11 board 13 groove (recess)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 培養される細胞が接着しない、非細胞接
着性の材料からなり、播種された細胞同士が接着して形
成される細胞集合体の外形を規制する凹部を有すること
を特徴とした接着依存性細胞の外形制御集合体形成用基
板。
1. A non-cell-adhesive material that does not adhere to cultured cells, and has a recessed portion that regulates the outer shape of a cell aggregate formed by adhering seeded cells to each other. A substrate for forming an outer shape control aggregate of adhesion-dependent cells.
【請求項2】 請求項1記載の接着依存性細胞の外形制
御集合体形成用基板を培養容器に収容し、該基板上に培
養液を供給し、前記基板凹部内に多数の細胞を播種し、
所要条件に維持して、基盤凹部底部に沈殿した細胞同士
を互いに接着させて、多数の細胞が接着した細胞集合体
の外形がほぼ凹部の形状に沿うように凹部壁面で規制し
つつ、生育させることを特徴とする細胞培養方法。
2. A substrate for forming an outer shape control aggregate of adhesion-dependent cells according to claim 1 is housed in a culture container, a culture solution is supplied onto the substrate, and a large number of cells are seeded in the recesses of the substrate. ,
Maintaining the required conditions, cells that have settled to the bottom of the base recess are allowed to adhere to each other, and the cell aggregate to which a large number of cells have adhered is grown while the outer shape of the cell aggregate is regulated by the recess wall surface so as to follow the shape of the recess. A method for culturing cells, which comprises:
JP2001243948A 2001-08-10 2001-08-10 Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture Pending JP2003052361A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001243948A JP2003052361A (en) 2001-08-10 2001-08-10 Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001243948A JP2003052361A (en) 2001-08-10 2001-08-10 Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture

Publications (1)

Publication Number Publication Date
JP2003052361A true JP2003052361A (en) 2003-02-25

Family

ID=19073954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001243948A Pending JP2003052361A (en) 2001-08-10 2001-08-10 Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture

Country Status (1)

Country Link
JP (1) JP2003052361A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361781B2 (en) 2006-01-24 2013-01-29 Brown University Cell aggregation and encapsulation device and method
US8501476B2 (en) 2009-10-07 2013-08-06 Brown University Assays and methods for fusing cell aggregates to form proto-tissues
JP2014187971A (en) * 2013-03-28 2014-10-06 Lsi Medience Corp Hepatocyte culture basal plate and hepatocyte culture method
JP2015511487A (en) * 2012-03-13 2015-04-20 インスティテュート オブ ジェネティックス アンド ディベロップメンタル バイオロジー,チャイニーズ アカデミー オブ サイエンシズ Reprogramming of cells by 3D culture
US9243278B2 (en) 2011-09-22 2016-01-26 Brown University Mechanotransduction by the synergistic action of heterotypic cell interactions
US9468680B2 (en) 2011-09-22 2016-10-18 Brown University Differential effects of drugs on transport in a multi-layer 3D spheroid model

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361781B2 (en) 2006-01-24 2013-01-29 Brown University Cell aggregation and encapsulation device and method
US9587213B2 (en) 2006-01-24 2017-03-07 Brown University Methods and devices for encapsulating cells
US8501476B2 (en) 2009-10-07 2013-08-06 Brown University Assays and methods for fusing cell aggregates to form proto-tissues
US9243278B2 (en) 2011-09-22 2016-01-26 Brown University Mechanotransduction by the synergistic action of heterotypic cell interactions
US9468680B2 (en) 2011-09-22 2016-10-18 Brown University Differential effects of drugs on transport in a multi-layer 3D spheroid model
JP2015511487A (en) * 2012-03-13 2015-04-20 インスティテュート オブ ジェネティックス アンド ディベロップメンタル バイオロジー,チャイニーズ アカデミー オブ サイエンシズ Reprogramming of cells by 3D culture
US9650602B2 (en) 2012-03-13 2017-05-16 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences Reprogramming cells by three-dimensional cultivation
JP2014187971A (en) * 2013-03-28 2014-10-06 Lsi Medience Corp Hepatocyte culture basal plate and hepatocyte culture method

Similar Documents

Publication Publication Date Title
JP6069384B2 (en) Temperature-responsive cell culture equipment and method for producing the same
Khetani et al. Engineering tissues for in vitro applications
CN201193228Y (en) Three-dimensional cell-culturing insert, manufacturing equipment thereof and kit
CN101048493B (en) Cellular tissue microchip and method of forming cellular tissue
CN107257850A (en) High flux aggregation and the device of operation for mammalian cell
JP5676265B2 (en) Cell storage method and cell transport method
JPH06327462A (en) Formation of cell aggregate
CN106146912A (en) A kind of calcium alginate hydrogel with three-dimensional micro-pattern and preparation method thereof
WO2020213634A1 (en) Cell culture device and use of same
WO2010134606A1 (en) Method for inducing differentiation of embryonic stem cells or artificial pluripotent stem cells
CA3071436A1 (en) Artificial cartilage and method for its production
JP2010136706A (en) Cell culture carrier
JP2003052361A (en) Base plate for forming aggregate with controlled outline of adhesion-depending cell and method for cell culture
US5264359A (en) Methods for large-scale cultivation of animal cells and for making supporting substrata for the cultivation
CN112424333A (en) System for cell culture in a bioreactor
US9260686B2 (en) Tubular bioreactor system for use in bone and cartilage tissue engineering
JP6659059B2 (en) Method for producing three-dimensional tissue having vasculature, and three-dimensional tissue containing gel having vasculature
JPH08131153A (en) Cell culture container, its production and culture
US20210171888A1 (en) Insertable culture container and kit for three-dimensional cell culture, and three-dimensional cell co-culture method using same
CN112972712B (en) Hot-pressing sterilization program for processing biological ink and application of hot-pressing sterilization program in human liver organoid 3D model construction
Ferro et al. Three-dimensional (3D) cell culture conditions, present and future improvements
JPH06277050A (en) Immobilization material for animal cell and culture method
JP2012000097A (en) Proliferation method for tissue stem cell and tissue stem cell obtained thereby
Duvar et al. Scale up cultivation of primary human umbilical vein endothelial cells on microcarriers from spinner vessels to bioreactor fermentation
JPS6225974A (en) Gelatinous composition consisting of collagen